University of Oxford
Oxford, Oxfordshire, United Kingdom
Purpose
To investigate a new human leukocyte antigen E (HLA-E) messenger ribonucleic acid (mRNA) vaccine platform to support the development of improved vaccines to treat and prevent diseases that adversely affect the world’s poorest populations.
Division
Gender Equality, Global Health
Date
November 2023
Region Served
GLOBAL
Committed amount
$1,978,240
Grant topic
Discovery and Translational Sciences, Empower Women and Girls
Duration (months)
49
Grantee location
Oxford, Oxfordshire, United Kingdom
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.